CABS-ACSB FREE Webinar - Monoclonal antibodies versus Filoviruses
June-17-2025
The topic Monoclonal antibodies versus Filoviruses: A quest for countermeasures against the world’s deadliest viruses is presented by Logan Banadyga, National Microbiology Laboratory, Public Health Agency of Canada.
Filoviruses were first described in 1967, following an outbreak of Marburg virus in Germany and Yugoslavia that was linked to monkeys imported from Uganda. Since then, over 50 outbreaks have been recorded, each caused by one of the six currently known human-pathogenic filoviruses. Disease caused by these viruses is often severe, and case fatality rates have approached 90% in some outbreaks. Ebola virus is arguably the most infamous filovirus and has been responsible for the majority of filovirus outbreaks, including the devastating 2013-2016 West African epidemic that resulted in over 28,000 cases primarily in Sierra Leone, Liberia, and Guinea. The unprecedented nature of this outbreak galvanized countermeasure development and ultimately led to the clinical licensure of a handful of vaccines and therapeutics. Among the most promising therapeutics for treating Ebola virus disease are monoclonal antibodies, which bind to the virus and prevent it from infecting other cells. Much of the work demonstrating the efficacy of monoclonal antibodies against Ebola virus was pioneered at Canada’s National Microbiology Laboratory, and this talk will focus on the role that the Laboratory continues to play in advancing these molecules as novel treatments, prophylactics, and diagnostics for some of the world’s deadliest viruses.
The webinar will
Canadian Biosafety Symposium 2025
September-23-2025
Canadian Biosafety Symposium 2025
Delta Ottawa City Centre,
Join us in Ottawa, ON from September 23-25, 2025 for Canada’s annual event for biosafety professionals and personnel involved in biosafety and/or biocontainment facilities.
The Canadian Biosafety Symposium will feature presentations on an array of biosafety topics, including emergency management for labs, building a biosafety culture, biosafety and public health, emerging and re-emerging diseases, laboratory acquired infections, ergonomics and safety, biowaste management and disinfection, regulations, airflow, ventilation, design and biosafety, animal issues, audits and inspections, occupational health and surveillance. It will be a unique opportunity for the biosafety community to learn and share knowledge with colleagues from across Canada and other countries.
The Canadian Biosafety Symposium brings together participants working across the biosafety field in universities, government and the private sector, such as:
- Laboratory managers and administrators
- Academic and government laboratory researchers
- Government regulators
- Biocontainment professionals
- Equipment and facilities providers
- Containment facility design and operation specialists
- Risk assessment and safety specialists
The event will feature prominent containment and biosafety specialists, and will involve presentations by the Canadian and international biosafety community selected from abstracts and papers that are currently being welcomed from all sources. All topics related to biological safety are welcome.
For more information: https://www.cabs-acsb.ca/Symposium.aspx